By supporting your body's master antioxidant levels with high-bioavailability supplements, you are nourishing your skin from the foundation up." Why Transparency Matters in Your Choice The supplement industry can be difficult to navigate
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate consistent risk reductions for mortality, myocardial infarction, stroke, heart failure, and renal outcomes, irrespective of their effects on glycemia
View other panels Physician Review Hormone replacement and peptide decisions require clinical review, contraindication screening and follow-up monitoring
Accessed 11/3/2020, Hitier M, Barbier C, Marie-Aude T, Moreau S, Courtheoux P, Patron V
We offer franchise opportunities to: Medical representatives looking to start their venture Wholesalers who want to expand their product portfolio Doctors interested in supplement distribution for patients Our focus is on building strong, reliable partnerships